A study presented at the annual meeting of the American College of Rheumatology found that Medicaid patients with systemic lupus erythematosus had significantly higher 30-day mortality rates after coronary revascularization procedures, compared with patients with diabetes mellitus who had the same procedures.
Mortality risk higher post-coronary revascularization in SLE vs. DM
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.